SCHEMBL7673906

SCHEMBL7673906

CCCc1cnc(-c2ccccc2Oc2cccc(C)c2C)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.39
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ CYP1A2 P05177 3/20 0.37
▸ CYP2C19 P33261 3/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ SREBF2 Q12772 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ OXTR P30559 2/20 0.35
▸ AVPR2 P30518 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SENP8 Q96LD8 1/20 0.34
▸ SENP7 Q9BQF6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7668578 0.80 L3MBTL1 (0.36) NPSR1CYP1A2CYP2C19CYP2D6CYP3A4
SCHEMBL7667019 0.78 TRPA1 (0.41) L3MBTL1SREBF2ALDH1A1HTT
SCHEMBL7664382 0.77 SLC6A2 (0.43) NPSR1L3MBTL1SREBF2MAPTNPC1
SCHEMBL7666933 0.77 CYP11B1 (0.42) CYP1A2CYP2C19CYP2D6CYP3A4SREBF2
SCHEMBL7664578 0.76 GRM5 (0.38) MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL7664066 0.72 BCL2L2 (0.37) NPSR1CYP2D6L3MBTL1SREBF2MAPT
SCHEMBL7664751 0.72 HTR2A (0.40) L3MBTL1SLC6A4ALOX15
SCHEMBL7666947 0.71 FEN1 (0.38) MEN1KMT2ANPSR1L3MBTL1MAPT
SCHEMBL10462079 0.70 PDE5A (0.41) SREBF2
SCHEMBL10462078 0.70 PDE5A (0.41) SREBF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback